1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The infant and young children antipyretic medicine market is in a period of rapid transformation, shaped by evolving clinical standards, regulatory requirements, and increasing parental expectations. Market participants are adapting to advancing technologies and rising scrutiny on product safety to address a segment central to pediatric care.
Market Snapshot: Infant and Young Children Antipyretic Medicine
The global market for antipyretic medications designed for infants and young children continues to expand, underpinned by robust demand for effective fever management solutions. Current growth is driven by a blend of clinical, regulatory, and consumer trends. Digitalization in healthcare and a heightened emphasis on transparent ingredient labeling enhance accessibility and caregiver trust. The market demonstrates noteworthy activity, with leading pharmaceutical and biotechnology players investing in innovative delivery methods and supply chain resilience.
Scope & Segmentation
This comprehensive study examines the infant and young children antipyretic medicine market across key product and regional dimensions, reflecting the segment’s complexity and strategic importance.
- Dosage Forms: Includes drops, suspension, syrup, and tablet formats, each tailored to distinct age groups or administration requirements.
- Active Ingredients: Focuses on ibuprofen and paracetamol, which serve varied safety and efficacy needs across pediatric subpopulations.
- Administration Routes: Covers oral and rectal routes, with product designs accommodating patient age and clinical scenarios.
- Distribution Channels: Considers offline points such as hospitals and pharmacies, as well as online eCommerce platforms and direct retail websites.
- Age Groups: Segments include 0–1 years, 2–5 years, and 6 years and above, aligning with developmental dosing and palatability considerations.
- Regions: Analysis spans Americas (including specific US states and broader countries), Europe, Middle East, Africa, and Asia-Pacific to capture growth divergences and policy variations.
- Technologies: Explores the role of digital health tools, smart dispensing devices, and analytics platforms in product innovation and delivery.
Primary Keyword: Infant and Young Children Antipyretic Medicine
Key Takeaways
- Market development hinges on ongoing clinical innovation and swift adaptation to regulatory shifts in excipient transparency and age-appropriate safety testing.
- Caregivers show rising demand for user-friendly formulations, promoting advances in dosage delivery and real-time health monitoring integration.
- Consumer preference is evolving towards formulations featuring plant-based or botanical adjuncts, reflecting wellness trends without compromising treatment efficacy.
- Emerging partnerships between pharmaceutical, biotechnology, and academic stakeholders accelerate co-branded offering development and clinical validation cycles.
- Companies building resilient, multi-tiered supply chains and transparent sourcing models are better insulated against tariff volatility and procurement risks.
Tariff Impact
Recent changes in United States tariffs targeting pharmaceutical ingredients have elevated costs within the pediatric antipyretic value chain and led to adjustments in sourcing and production strategies. Formulators are turning toward alternative suppliers and developing proprietary excipients to maintain stable pricing and supply. This environment has spurred process optimization and fostered the adoption of integrated supply chain models that reduce dependence on single-source suppliers and enhance delivery reliability.
Methodology & Data Sources
This analysis synthesizes insights from primary interviews with pediatric professionals, pharmacists, and industry leaders, along with quantitative surveys among caregivers. Secondary research incorporates peer-reviewed journals, regulatory documents, trade databases, and digital analytics. Analytical frameworks like SWOT and PESTEL provide structured guidance in interpreting and validating all findings.
Why This Report Matters
- Enables senior decision-makers to anticipate regulatory and market shifts by providing actionable segmentation and channel forecasts.
- Supports investment prioritization for product development, supply chain realignment, and partnership opportunities within a fast-evolving sector.
- Equips stakeholders to address both clinical efficacy and consumer trust, key for sustaining growth and compliance in pediatric fever management.
Conclusion
The infant and young children antipyretic medicine market will continue to evolve, balancing innovation, policy adjustments, and caregiver priorities. Organizations that integrate science, supply chain flexibility, and digital engagement will secure a lasting position in pediatric healthcare delivery.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid growth in pediatric-friendly dissolvable antipyretic strips and chewable formats for toddlers
5.2. Surge in demand for natural plant-derived antipyretic syrups marketed to health-conscious parents
5.3. Innovative microdosing technologies enabling precise antipyretic administration for neonates
5.4. Integration of smart dosing spoons with mobile apps to ensure accurate pediatric antipyretic delivery
5.5. Regulatory emphasis on child-specific pharmacokinetic trials improving antipyretic safety profiles
5.6. Expansion of e-commerce channels boosting direct-to-consumer sales of pediatric fever management products
5.7. Development of allergen-free antipyretic formulations without artificial colors for sensitive infants
5.8. Advances in preservative-free packaging solutions enhancing shelf life and sterility of infant medicines
5.9. Rising popularity of combination antipyretic and analgesic pediatric formulations for comprehensive relief
5.10. Collaborative initiatives between pharma and pediatric experts to optimize infant dosing protocols in antipyretics
5.2. Surge in demand for natural plant-derived antipyretic syrups marketed to health-conscious parents
5.3. Innovative microdosing technologies enabling precise antipyretic administration for neonates
5.4. Integration of smart dosing spoons with mobile apps to ensure accurate pediatric antipyretic delivery
5.5. Regulatory emphasis on child-specific pharmacokinetic trials improving antipyretic safety profiles
5.6. Expansion of e-commerce channels boosting direct-to-consumer sales of pediatric fever management products
5.7. Development of allergen-free antipyretic formulations without artificial colors for sensitive infants
5.8. Advances in preservative-free packaging solutions enhancing shelf life and sterility of infant medicines
5.9. Rising popularity of combination antipyretic and analgesic pediatric formulations for comprehensive relief
5.10. Collaborative initiatives between pharma and pediatric experts to optimize infant dosing protocols in antipyretics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Antipyretic Medicine for Infants & Young Children Market, by Dosage Form
8.1. Introduction
8.2. Drops
8.3. Suspension
8.4. Syrup
8.5. Tablet
8.2. Drops
8.3. Suspension
8.4. Syrup
8.5. Tablet
9. Antipyretic Medicine for Infants & Young Children Market, by Active Ingredient
9.1. Introduction
9.2. Ibuprofen
9.3. Paracetamol
9.2. Ibuprofen
9.3. Paracetamol
10. Antipyretic Medicine for Infants & Young Children Market, by Administration Route
10.1. Introduction
10.2. Oral
10.3. Rectal
10.2. Oral
10.3. Rectal
11. Antipyretic Medicine for Infants & Young Children Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Hospital
11.2.2. Pharmacy
11.3. Online
11.3.1. Ecommerce Platform
11.3.2. Retail Website
11.2. Offline
11.2.1. Hospital
11.2.2. Pharmacy
11.3. Online
11.3.1. Ecommerce Platform
11.3.2. Retail Website
12. Antipyretic Medicine for Infants & Young Children Market, by Age Group
12.1. Introduction
12.2. 0-1 Years
12.3. 2-5 Years
12.4. 6 Years and Above
12.2. 0-1 Years
12.3. 2-5 Years
12.4. 6 Years and Above
13. Americas Antipyretic Medicine for Infants & Young Children Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antipyretic Medicine for Infants & Young Children Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antipyretic Medicine for Infants & Young Children Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Kenvue Inc.
16.3.2. Reckitt Benckiser Group plc
16.3.3. Haleon plc
16.3.4. Sanofi SA
16.3.5. Perrigo Company plc
16.3.6. Novartis AG
16.3.7. Bayer AG
16.3.8. Boehringer Ingelheim International GmbH
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Sun Pharmaceutical Industries Ltd.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Kenvue Inc.
16.3.2. Reckitt Benckiser Group plc
16.3.3. Haleon plc
16.3.4. Sanofi SA
16.3.5. Perrigo Company plc
16.3.6. Novartis AG
16.3.7. Bayer AG
16.3.8. Boehringer Ingelheim International GmbH
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Sun Pharmaceutical Industries Ltd.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHAI
FIGURE 26. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHAI
FIGURE 26. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PARACETAMOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PARACETAMOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RETAIL WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RETAIL WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 0-1 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 0-1 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 2-5 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 2-5 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 6 YEARS AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 6 YEARS AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 176. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 177. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 178. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 192. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 220. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 221. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 222. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 234. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ANTIPYRETIC MEDICINE F
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PARACETAMOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PARACETAMOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RETAIL WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY RETAIL WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 0-1 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 0-1 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 2-5 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 2-5 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 6 YEARS AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY 6 YEARS AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 176. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 177. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 178. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 192. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 220. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 221. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 222. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 234. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA ANTIPYRETIC MEDICINE FOR INFANTS & YOUNG CHILDREN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ANTIPYRETIC MEDICINE F
Samples
LOADING...
Companies Mentioned
The companies profiled in this Antipyretic Medicine for Infants & Young Children market report include:- Kenvue Inc.
- Reckitt Benckiser Group plc
- Haleon plc
- Sanofi SA
- Perrigo Company plc
- Novartis AG
- Bayer AG
- Boehringer Ingelheim International GmbH
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
